US$ 29.76
innovent glp-1 China's says its works better than Novo's semaglutide in diabetes study Glucagon-Like Peptide 1 (GLP-1) Agonist
Description
Are GLP-1 and Ozempic injections safe for long-term use

Some GLP-1 analogues may influence glutamatergic and GABAergic pathways, potentially contributing to therapeutic effects in conditions such as epilepsy, autism spectrum disorders, and addiction, although further validation is required

Hypoglycaemia : GLP-1 agonists have a low intrinsic risk of causing low blood glucose when used alone

Those who had nausea or vomiting while using Liraglutide 3.0 mg lost 9.2 kg per year, compared to 6.3 kg for those who did not

Author Contributions Concept and design: Angela D

Subscribe to NPR's Health newsletter
